In an earlier study, Hua et al. [68] showed that preconditioning with Pam3Csk4, a TLR2 agonist, 24 hours prior to 1 hour of cerebral ischemia significantly reduced brain infarct size, possibly via an effect on blood brain barrier integrity. The gene discussed is TLR2; the disease is Cerebral ischemia.